July 2020 FDA Recall Fentanyl Citrate by Pfizer Inc.
D-1446-2020 - Lack of Assurance of Sterility; potential loose metal overseal crimp defects.

This Class II drug recall was voluntarily initiated by Pfizer Inc. on July 20, 2020 for the product Fentanyl Citrate. The FDA reported the reason for recall as lack of assurance of sterility; potential loose metal overseal crimp defects.. The product was distributed in United States including Puerto Rico and the recall is currently terminated.

Recall Number: D-1446-2020

Reason for Recall
Lack of Assurance of Sterility; potential loose metal overseal crimp defects.
Initiated
07-20-2020
Reported
08-12-2020
Quantity
19,144 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
United States including Puerto Rico
Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL) 2 mL Single-dose Fliptop Vials, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA NDC 0409-9094-12

Batch or Lot Expiration Information

Lot# Lots: Tray lot: 13405DK Vial lot: 13-405 DK Exp. 1JUL2021, Tray lot: 17096DK Vial lot: 17-096-DK Exp. 1NOV2021